Finance

Beta
Lists
ALIVUS:NSE
Alivus Life Sciences Ltd
₹1,036.00
-1.11%
(-11.60) 1D
Jun 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
₹1,059.30
High
₹1,074.40
Low
₹1,029.60
Mkt. cap
127.16B
Avg. vol.
97.89K
Volume
74.62K
P/E ratio
22.57
52-wk high
₹1,148.40
52-wk low
₹819.00
EPS
₹45.90
No. of employees
2K
Open
₹1,059.30
High
₹1,074.40
Low
₹1,029.60
Mkt. cap
127.16B
Avg. vol.
97.89K
Volume
74.62K
P/E ratio
22.57
52-wk high
₹1,148.40
52-wk low
₹819.00
EPS
₹45.90
No. of employees
2K
News stories
From sources across the web
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2.2K
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitealivus.com
Last report
May 14, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹13.22 / ₹11.70
+12.99%beat
Revenue / Est. (INR)
6.89B / 6.75B
+2.14%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.02B
5.88B
6.73B
6.89B
Cost of goods sold
2.70B
2.49B
2.76B
2.71B
Cost of revenue
2.70B
2.49B
2.76B
2.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
615.77M
664.00M
663.70M
781.22M
Operating expense
1.76B
1.78B
1.85B
2.24B
Total operating expenses
4.47B
4.27B
4.61B
4.95B
Operating income
1.55B
1.61B
2.12B
1.94B
Other non operating income
89.85M
147.20M
139.28M
227.78M
EBT including unusual items
1.63B
1.74B
1.98B
2.16B
EBT excluding unusual items
1.63B
1.74B
2.24B
2.16B
Income tax expense
414.46M
441.11M
481.31M
531.38M
Effective tax rate
25.43%
25.33%
24.26%
24.62%
Other operating expenses
975.73M
934.91M
988.28M
1.26B
Net income
1.22B
1.30B
1.50B
1.63B
Net profit margin
20.19%
22.11%
22.33%
23.60%
Earnings per share
9.88
10.58
13.80
13.22
Interest and investment income
-
-
-
-
Interest expense
-12.51M
-13.18M
-14.94M
-13.09M
Net interest expenses
-12.51M
-13.18M
-14.94M
-13.09M
Depreciation and amortization charges
170.64M
184.35M
196.58M
202.00M
EBITDA
1.70B
1.78B
2.25B
2.13B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer